Deskripsi
Methylation-specific PCR or bisulfite sequencing results for the CES1 promoter region in CRPC cells, confirming melatonin-induced demethylation.
Figure 24
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 24: Methylation-specific PCR or bisulfite sequencing results for the CES1 promoter region in CRPC cells, confirming melatonin-induced demethylation.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Methylation-specific PCR or bisulfite sequencing results for the CES1 promoter region in CRPC cells, confirming melatonin-induced demethylation." /> <figcaption>Figure 24. Methylation-specific PCR or bisulfite sequencing results for the CES1 promoter region in CRPC cells, confirming melatonin-induced demethylation.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>